NYSE:HQL · New York Stock Exchange
+$0.11 today
Vol 0.13M · Avg 0.11M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Company filings are the primary source for understanding what changed inside Tekla Life Sciences Investors before the market fully reacts. Review recent HQL disclosures alongside price history and peer context to identify new risks, accounting changes, strategic updates, capital allocation decisions, and operating details that may affect the intrinsic value case.
Price History
Dividend-adjusted closing price
Change
+72.12%
Period High
$20.83
Period Low
$11.44
Latest
$19.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Gladstone Investment Corp.
NASDAQ:GAIN
$619.63M
Eagle Point Credit Company Inc.
NYSE:ECC
$510.33M
Gladstone Capital Corporation
NASDAQ:GLAD
$441.47M
Crescent Capital BDC, Inc.
NASDAQ:CCAP
$409.73M
Source Capital, Inc.
NYSE:SOR
$383.40M
Barings Corporate Investors
NYSE:MCI
$356.85M
CION Investment Corporation
NYSE:CION
$318.15M
BlackRock TCP Capital Corp.
NASDAQ:TCPC
$281.91M
PennantPark Investment Corporation
NYSE:PNNT
$225.27M
What is the latest HQL filing?
The latest filing shown is 3 dated Jun 11, 2026.
How many recent filings does HQL have?
Intrinsic Alpha currently shows 20 recent filings for HQL.
Explore More
Continue the stock analysis
Jump to another research area for this company.